Artiva Biotherapeutics, Inc.
USD10.03
-0.10 (-0.99%)
CEO
Fred Aslan
IPO Date
2024-07-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$10.56
Prev. Close
$10.13
Day Low
$9.76
Day High
$11.30
52W Low
$2.22
52W High
$14.53
Market Cap
$0.25B
Volume
0.57M
| 84,124 |
| $9.93 |
| 23 Jul 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | P-Purchase | Acquired | 59,880 | $9.96 |
| 23 Jul 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | P-Purchase | Acquired | 6,522 | $8.94 |
| 20 Jul 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | P-Purchase | Acquired | 152,472 | $8.93 |
| 20 Jul 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | P-Purchase | Acquired | 7,882 | $8.95 |
| 14 Jul 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | P-Purchase | Acquired | 15,102 | $8.97 |
| 14 Jul 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | P-Purchase | Acquired | 6,552 | $8.94 |
| 29 Jun 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | P-Purchase | Acquired | 31,000 | $8.88 |
| 29 Jun 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | P-Purchase | Acquired | 1,876 | $8.98 |